Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
NCT03026946Phase 3Unknown
- Sponsor
- University Medical Center Groningen
- Start
- May 2017
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of alitretinoin in Hand Eczema (HE), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
alitretinoin
03
Conditions
Hand Eczema (HE)
Beyond the preview
Go deeper on NCT03026946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026946.